Actively Recruiting
NIRS in Congenital Heart Defects - Correlation With Echocardiography
Led by McGill University Health Centre/Research Institute of the McGill University Health Centre · Updated on 2025-06-17
100
Participants Needed
1
Research Sites
320 weeks
Total Duration
On this page
Sponsors
M
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead Sponsor
M
Medtronic
Collaborating Sponsor
AI-Summary
What this Trial Is About
Neonatal patients with congenital heart defects (CHD) have changing physiology in the context of transitional period. Patients with CHD are at risk of low perfusion status or abnormal pulmonary blood flow. Near infrared spectroscopy has been used in neonatal intensive care units (NICU) to measure end-organ perfusion. The investigator plan on monitoring newborns with CHD admitted to the NICU with NIRS and echocardiography during the first week of life and correlate measures of perfusion from Dopplers to cerebral and renal NIRS.
CONDITIONS
Official Title
NIRS in Congenital Heart Defects - Correlation With Echocardiography
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Newborns with congenital heart defects such as tetralogy of Fallot, truncus arteriosus, D-transposition of great arteries, pulmonary stenosis, aortic stenosis, coarctation of the aorta, double inlet left ventricle, atrioventricular canal, double outlet right ventricle, hypoplastic left heart syndrome, tricuspid atresia, and pulmonary atresia with intact ventricular septum admitted to the NICU
- Term infants admitted and monitored in the NICU with antenatal suspicion of coarctation of the aorta ruled out postnatally
- Newborns admitted consecutively at the Montreal Children's Hospital NICU from January 2018 to January 2020
You will not qualify if you...
- Premature babies born before 34 weeks of estimated gestational age
- Parents who do not consent to their baby's participation
- Withdrawal of parental consent at any time during the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mcgill University Health Centre
Montreal, Quebec, Canada, H4A 3J1
Actively Recruiting
Research Team
G
Gabriel Altit, MD
CONTACT
J
Jennifer Gardner
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here